The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Open accessAbstract
Uptake of the Parkinsonism-inducing toxin, 1-methyl-4-phenylpyridinium (MPP(+)), into dopaminergic terminals is thought to block Complex I activity leading to ATP loss and overproduction of reactive oxygen species (ROS). The present study indicates that MPP(+)-induced ROS formation is not mitochondrial in origin but results from intracellular dopamine (DA) oxidation. Although a mean lethal dose of MPP(+) led to ROS production in identified dopaminergic neurons, toxic doses of the Complex I inhibitor rotenone did not. Concurrent with ROS formation, MPP(+) redistributed vesicular DA to the cytoplasm prior to its extrusion from the cell by reverse transport via the DA transporter. MPP(+)-induced DA redistribution was also associated with cell death. Depleting cells of newly synthesized and/or stored DA significantly attenuated both superoxide production and cell death, whereas enhancing intracellular DA content exacerbated dopaminergic sensitivity to MPP(+). Lastly, depleting cells of DA in the presence of succinate completely abolished MPP(+)-induced cell death. Thus, MPP(+) neurotoxicity is a multi-component process involving both mitochondrial dysfunction and ROS generated by vesicular DA displacement. These results suggest that in the presence of a Complex I defect, misregulation of DA storage could lead to the loss of nigrostriatal neurons in Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Superoxide radical and superoxide dismutases
Fridovich, I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000525 · Cited by 3,455
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
Turrens, J. F., & Boveris, A. (1980) · Biochemical Journal · doi:10.1042/bj1910421 · Cited by 1,601
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Mitochondria and neuronal survival
Nicholls, D. G., & Budd, S. L. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.1.315 · Cited by 1,243
Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126
Royall, J. A., & Ischiropoulos, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1222 · Cited by 1,119
Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine
Bindokas, V., Jordan, J., Lee, C., & Miller, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-04-01324.1996 · Cited by 859
Dugan, L., Sensi, S., Canzoniero, L., Handran, S., Rothman, S., Lin, T., Goldberg, M., & Choi, D. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06377.1995 · Cited by 772
Carboxyfullerenes as neuroprotective agents
Dugan, L. L., Turetsky, D. M., Du, C., Lobner, D., Wheeler, M., Almli, C. R., Shen, C. K.-F., Luh, T.-Y., Choi, D. W., & Lin, T.-S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9434 · Cited by 748
Sulzer, D., Chen, T., Lau, Y., Kristensen, H., Rayport, S., & Ewing, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-04102.1995 · Cited by 688
Berman, S. B., & Hastings, T. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731127.x · Cited by 664
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 631
Przedborski, S., Jackson-Lewis, V, Yokoyama, R., Shibata, T., Dawson, V. L., & Dawson, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4565 · Cited by 624
A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
Liu, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90425-c · Cited by 594
Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.
Hastings, T. G., Lewis, D. A., & Zigmond, M. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1956 · Cited by 547
Oxidants in mitochondria: from physiology to diseases
Richter, C., Gogvadze, V., Laffranchi, R., Schlapbach, R., Schweizer, M., Suter, M., Walter, P., & Yaffee, M. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00012-s · Cited by 541
Gerlach, M., & Riederer, P. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291788 · Cited by 498
Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical
Benov, L., Sztejnberg, L., & Fridovich, I. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00163-4 · Cited by 496
Przedborski, S., Kostic, V, Jackson-Lewis, V, Naini, A., Simonetti, S., Fahn, S., Carlson, E., Epstein, C., & Cadet, J. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01658.1992 · Cited by 456
Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., & Amara, S. G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00960.1997 · Cited by 444
Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
Fischer, J. F., & Cho, A. K. (1979) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31549-1 · Cited by 441
Budd, S. L., & Nicholls, D. G. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67062282.x · Cited by 434
Takahashi, N., Miner, L. L., Sora, I., Ujike, H., Revay, R. S., Kostic, V., Jackson-Lewis, V., Przedborski, S., & Uhl, G. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9938 · Cited by 429
Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
Lotharius, J., Dugan, L. L., & O’Malley, K. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01284.1999 · Cited by 403
Self-citationThe Mitochondrion in Cell Death Control: Certainties and Incognita
Loeffler, M., & Kroemer, G. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4833 · Cited by 394
Scott, I. D., & Nicholls, D. G. (1980) · Biochemical Journal · doi:10.1042/bj1860021 · Cited by 393
Titrating the Effects of Mitochondrial Complex I Impairment in the Cell Physiology
Barrientos, A., & Moraes, C. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16188 · Cited by 383
Wang, Y.-M., Gainetdinov, R. R., Fumagalli, F., Xu, F., Jones, S. R., Bock, C. B., Miller, G. W., Wightman, R. M., & Caron, M. G. (1997) · Neuron · doi:10.1016/s0896-6273(00)80419-5 · Cited by 376
Bioenergetic and oxidative stress in neurodegenerative diseases
Bowling, A. C., & Beal, M. F. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00055-b · Cited by 366
Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture
Michel, P. P., & Hefti, F. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260405 · Cited by 338
Fon, E. A., Pothos, E. N., Sun, B.-C., Killeen, N., Sulzer, D., & Edwards, R. H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80418-3 · Cited by 337
Hasegawa, E., Takeshige, K., Oishi, T., Murai, Y., & Minakami, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90498-c · Cited by 319
Cassarino, D. S., Parks, J. K., Parker, W. D., & Bennett, J. P. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00083-0 · Cited by 304
Takeshige, K., & Minakami, S. (1979) · Biochemical Journal · doi:10.1042/bj1800129 · Cited by 298
Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells
Rottenberg, H., & Wu, S. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00088-3 · Cited by 272
Ramsay, R. R., Salach, J. I., & Singer, T. P. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80483-1 · Cited by 272
6-Hydroxydopamine: Evidence for Superoxide Radical as an Oxidative Intermediate
Heikkila, R. E., & Cohen, G. (1973) · Science · doi:10.1126/science.181.4098.456 · Cited by 259
Maker, H. S., Weiss, C., Silides, D. J., & Cohen, G. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb01631.x · Cited by 256
Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain
Chan, P., DeLanney, L. E., Irwin, I., Langston, J. W., & Di Monte, D. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02134.x · Cited by 241
Kristal, B. S., & Dubinsky, J. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020524.x · Cited by 228
Peter, D., Jimenez, J., Liu, Y., Kim, J., & Edwards, R. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37272-1 · Cited by 226
Budd, S. L., Castilho, R. F., & Nicholls, D. G. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01088-0 · Cited by 222
Ramsay, R. R., Krueger, M. J., Youngster, S. K., Gluck, M. R., Casida, J. E., & Singer, T. P. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11409.x · Cited by 209
Pre- and Postsynaptic Neurotoxic Effects of Dopamine Demonstrated by Intrastriatal Injection
Filloux, F., & Townsend, J. J. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1008 · Cited by 207
Mechanism of the neurotoxicity of MPTP: An update
(1990) · FEBS Letters · doi:10.1016/0014-5793(90)81315-f · Cited by 199
Andreyev, A., & Fiskum, G. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400565 · Cited by 187
Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice
Gainetdinov, R. R., Fumagalli, F., Wang, Y., Jones, S. R., Levey, A. I., Miller, G. W., & Caron, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051973.x · Cited by 178
Chinopoulos, C., Tretter, L., & Ádám‐Vizi, V. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730220.x · Cited by 162
Liang, N. Y., & Rutledge, C. O. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90332-x · Cited by 153
Dopamine Neuronal Transport Kinetics and Effects of Amphetamine
Jones, S. R., Joseph, J. D., Barak, L. S., Caron, M. G., & Wightman, R. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732406.x · Cited by 145
Dopamine D2 and D3 receptors inhibit dopamine release.
Tang, L., Todd, R. D., & O’Malley, K. L. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22405-3 · Cited by 143
Self-citationManganese Superoxide Dismutase Overexpression Attenuates MPTP Toxicity
Klivenyi, P., St. Clair, D., Wermer, M., Yen, H.-C., Oberley, T., Yang, L., & Beal, M. F. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0191 · Cited by 142
Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium.
Liu, Y., Roghani, A., & Edwards, R. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9074 · Cited by 124
Li, H., & Dryhurst, G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041530.x · Cited by 109
Denton, T. A., & Howard, B. D. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb02909.x · Cited by 107
Obata, T., & Chiueh, C. C. (1992) · Journal of Neural Transmission · doi:10.1007/bf01245361 · Cited by 106
Reinhard, J. F., Diliberto, E. J., Viveros, O. H., & Daniels, A. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.8160 · Cited by 102
Rollema, H., Damsma, G., Horn, A. S., Vries, J. B. D., & Westerink, B. H. C. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90071-3 · Cited by 98
Gluck, M. R., Krueger, M. J., Ramsay, R. R., Sablin, S. O., Singer, T. P., & Nicklas, W. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41844-8 · Cited by 93
Pileblad, E., & Carlsson, A. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90114-5 · Cited by 91
Mitochondrial Membrane Potential and the Permeability Transition in Excitotoxicity
Reynolds, I. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07816.x · Cited by 88
Daniels, A. J., & Reinhard, J. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60674-x · Cited by 87
Oxidation of Dopamine in the Presence of Cysteine: Characterization of New Toxic Products
Shen, X.-M., Fa, Z., & Dryhurst, G. (1997) · Chemical Research in Toxicology · doi:10.1021/tx960145c · Cited by 85
Krueger, M. J., Singer, T. P., Casida, J. E., & Ramsay, R. R. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91442-u · Cited by 84
Simbula, G., Glascott, P. A., Akita, S., Hoek, J. B., & Farber, J. L. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.2.c479 · Cited by 82
Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity
Zompo, M. D., Piccardi, M. P., Ruiu, S., Quartu, M., GESSA, G. L., & Vaccari, A. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13584.x · Cited by 69
Involvement of free radicals in MPP+ neurotoxicity against rat dopaminergic neurons in culture
Akaneya, Y., Takahashi, M., & Hatanaka, H. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11668-m · Cited by 53
Clarke, P. B. S., & Reuben, M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13229.x · Cited by 51
Packer, M. A., Miesel, R., & Murphy, M. P. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02165-5 · Cited by 45
Pileblad, E., Nissbrandt, H., & Carlsson, A. (1986) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-07431-0_54 · Cited by 44
Pileblad, E., Nissbrandt, H., & Carlsson, A. (1984) · Journal of Neural Transmission · doi:10.1007/bf01249093 · Cited by 43
SIRINATHSINGHJI, D. J. S., HEAVENS, R. P., & McBride, C. (1988) · Brain Research · doi:10.1016/0006-8993(88)91603-4 · Cited by 33
Reserpine prevents hydroxyl radical formation by MPP+ in rat striatum
Obata, T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01329-3 · Cited by 27
Cited by
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Self-citationMechanism of Oxidative Stress in Neurodegeneration
Gandhi, S., & Abramov, A. Y. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/428010 · Cited by 960
DJ‐1 has a role in antioxidative stress to prevent cell death
Taira, T., Saito, Y., Niki, T., Iguchi‐Ariga, S. M. M., Takahashi, K., & Ariga, H. (2004) · EMBO reports · doi:10.1038/sj.embor.7400074 · Cited by 853
Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?
Ischiropoulos, H., & Beckman, J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17638 · Cited by 747
Metadata
- Authors
- Lotharius, J., & O'Malley, K. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 49
- Pages
- 38581-38588
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2052122668
- Cited by
- 306
- References
- 75
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.